首页> 外文期刊>Critical reviews in oncology/hematology >Review of hematological indices of cancer patients receiving combined chemotherapy & radiotherapy or receiving radiotherapy alone
【24h】

Review of hematological indices of cancer patients receiving combined chemotherapy & radiotherapy or receiving radiotherapy alone

机译:癌症患者接受联合化学疗法和放疗或单独接受放疗的血液学指标的审查

获取原文
获取原文并翻译 | 示例
           

摘要

We observed the outcomes of chemotherapy with radiotherapy (CR) or radiotherapy (RT) alone for cancer patients of larynx, breast, blood and brain origins through complete blood count (CBC). Following were more depressed in CR patients: mean corpuscular hemoglobin-MCH & lymphocytes-LYM, hematocrit, mean corpuscular hemoglobin concentration-MCHC, hemoglobin-HB and red blood cells-RBC. In RT patients, following were more depressed: LYM,MCH and MCHC. Overall, in all cancer patients, the lymphocytes were depressed 52%. There existed a significant difference between white blood cells and RBC in both CR and RT patients. A significant moderate negative correlation is found in HB with the dose range 30-78 (Gray) given to the CR cancer patients. More number of CBC parameters affected in patients treated with CR and RT; but in less percentage as compared to patients who treated with RT alone. The cancer patients suffered from anemia along with immune modulations from the treatments. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
机译:我们通过全血细胞计数(CBC)观察了喉癌,乳腺癌,血液和脑源性癌症患者单独接受放疗(CR)或放疗(RT)化疗的结果。 CR患者的以下情况更为抑郁:平均血红蛋白-MCH和淋巴细胞-LYM,血细胞比容,平均血红蛋白浓度-MCHC,血红蛋白-HB和红细胞-RBC。在RT患者中,以下患者更加抑郁:LYM,MCH和MCHC。总体而言,在所有癌症患者中,淋巴细胞降低了52%。 CR和RT患者的白细胞和RBC之间存在显着差异。在HB中,CR癌症患者的剂量范围为30-78(灰色)时,存在明显的中度负相关。 CR和RT治疗的患者中更多的CBC参数受到影响;但与仅接受放疗的患者相比,所占的百分比更低。癌症患者患有贫血以及治疗中的免疫调节。 (C)2016 Elsevier Ireland Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号